Squawk on the Street

Stocks and Crypto Extend Slump, Exclusive With Take-Two CEO on Zynga Deal, and Gilead Sciences CEO on the Battle to Treat COVID

Jan 10, 2022
Ask episode
Chapters
Transcript
Episode notes